Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.
about
A Temporal Model of Human IgE and IgG Antibody FunctionEndogenous antibody responsiveness to epidermal growth factor receptor is associated with immunoglobulin allotypes and overall survival of patients with glioblastomaHumanization of an anti-p185HER2 antibody for human cancer therapyIsolation of cDNAs for two distinct human Fc receptors by ligand affinity cloningInhibition of acute vascular thrombosis in chimpanzees by an anti-human tissue factor antibody targeting the factor X binding siteIgG4 Characteristics and Functions in Cancer ImmunityComplement inhibitors to treat IgM-mediated autoimmune hemolysisA fluorescent biosensor reveals conformational changes in human immunoglobulin E Fc: implications for mechanisms of receptor binding, inhibition, and allergen recognitionHuman single-chain Fv immunoconjugates targeted to a melanoma-associated chondroitin sulfate proteoglycan mediate specific lysis of human melanoma cells by natural killer cells and complement.Adapting antibodies for clinical use.Efficacy of the fully human monoclonal antibody MOR102 (#5) against intercellular adhesion molecule 1 in the psoriasis-severe combined immunodeficient mouse model.H435-containing immunoglobulin G3 allotypes are transported efficiently across the human placenta: implications for alloantibody-mediated diseases of the newborn.Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in miceCloning immunoglobulin variable domains for expression by the polymerase chain reactionKinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection.Pretransplant IgG reactivity to apoptotic cells correlates with late kidney allograft loss.Functional characterization of an scFv-Fc antibody that immunotherapeutically targets the common cancer cell surface proteoglycan CSPG4Generation of a canine anti-EGFR (ErbB-1) antibody for passive immunotherapy in dog cancer patients.A repertoire of monoclonal antibodies with human heavy chains from transgenic miceNodular glomerulosclerosis with anti-glomerular basement membrane-like glomerulonephritis; a distinct pattern of kidney injury observed in smokers.Autoantibodies and cardiovascular dysfunction: cause or consequence?Reprogramming the immune system.Decreased dengue replication and an increased anti-viral humoral response with the use of combined Toll-like receptor 3 and 7/8 agonists in macaquesIsolation of highly active monoclonal antibodies against multiresistant gram-positive bacteria.The S228P mutation prevents in vivo and in vitro IgG4 Fab-arm exchange as demonstrated using a combination of novel quantitative immunoassays and physiological matrix preparation.Building antibodies from their genes.Genetically-engineered antibodies: tools for the study of diverse properties of the antibody molecule.The solution structures of two human IgG1 antibodies show conformational stability and accommodate their C1q and FcγR ligands.Immortalisation of human antibody producing cells.Immunoglobulin G2 antibodies promote neutrophil killing of Actinobacillus actinomycetemcomitans.Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjögren's syndrome and systemic lupus erythematosusCombined roles of human IgG subclass, alternative complement pathway activation, and epitope density in the bactericidal activity of antibodies to meningococcal factor h binding protein.CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaquesRecombinant human IgA expressed in insect cells.Bactericidal Immunity to Salmonella in Africans and Mechanisms Causing Its Failure in HIV Infection.A human anti-Pseudomonas aeruginosa serotype O6ad immunoglobulin G1 expressed in transgenic tobacco is capable of recruiting immune system effector function in vitro.Regulation of antibody production mediated by Fc gamma receptors, IgG binding factors, and IgG Fc-binding autoantibodies.Characterization of a mutated IgA2 antibody of the m(1) allotype against the epidermal growth factor receptor for the recruitment of monocytes and macrophages.Solution conformation of wild-type and mutant IgG3 and IgG4 immunoglobulins using crystallohydrodynamics: possible implications for complement activation.Macrophages are critical effectors of antibody therapies for cancer
P2860
Q21131207-D52C5665-CBA0-478A-8490-D31F47FB731FQ23914429-0D30E832-677F-4B5C-8CB6-9B07261953BBQ24561842-AF1A3DEE-FA4C-48A5-BCF2-788A6DF223C3Q24564255-6F935D71-926D-487A-93C1-912D346084E2Q24627747-FAE84D75-9796-4EB3-9570-74AEDB6E46C7Q26770244-C9717745-C282-40FD-B9AC-02F9429965A4Q26777628-77241B87-E46A-4B3A-B58F-E9D88FFD5E32Q30514536-717111E3-1C40-47A1-85A5-9C321530A9F5Q31904181-032F5EC0-08D1-4F3D-876F-3E674DF7A0F7Q33197771-D9CE5DEB-6D03-47E4-889D-B332630830C9Q33223886-16C49819-1623-4C93-ACA6-04FA5D3834CDQ33408913-2B1681C2-5651-4875-B3B6-83A3F4F5DFF7Q33707941-3ABB3AA8-C00D-46BD-92A3-A0FC94DF79B9Q33859027-82B09912-9BD0-4413-BC4D-EACF86FE7896Q33974253-FE6C7D0B-CFAE-4EFD-8291-C4EBD177C239Q33998148-87909B8F-E052-4E09-9840-6D4CA7371D64Q34055092-3551284D-9132-41F5-A10E-2A50B12F3949Q34240076-22B1A782-4D73-4F23-BD3C-555254C843B4Q34301539-5816D501-95BE-400D-9CA1-FEC32925FB6BQ34400641-E069DBB4-C86E-460A-93D9-DCD55F5A3EBBQ34473885-B54A1A43-F746-4D16-B681-87B7C7566EFFQ34792489-EEB1E57F-F70D-4B76-9BBE-3D2B2B811D4DQ34889330-B7597282-D55C-473D-A271-F1BB1822892BQ35112655-70CBADEF-4E3E-451B-9E8D-B1087FB94F6EQ35126618-7A23D74E-5418-4864-8B3E-323FA483D3B3Q35180027-AC3DA36C-77C2-4F84-BBE8-1BE68888D4FBQ35180033-1754FA0A-2DC3-48EE-8159-92B637DD4BFFQ35221593-FA3BFBCC-A36A-4A02-B3D4-717FF390A109Q35237160-A87D9AAC-B63A-48DE-84AA-F46085FF7125Q35395105-0DBB079F-4C0A-4B0F-831F-618DF67B3481Q35548228-B81D48C2-3534-4BFF-9D71-9A088CA3EE5BQ35665404-80AA6826-76B5-4655-BC66-9AC6A789F45FQ35693333-57DC9797-F850-48B4-9574-E020178F09A4Q35698255-7560536B-25AA-4DD0-97EA-F97FAE40D88CQ35983385-56B3EA03-47C3-47EB-B0E3-8BA322F1BF1AQ36094806-BD92D018-23BF-4757-9234-CE8F24EC0609Q36116253-350F0D7D-5776-4E60-A166-51D63AB61E44Q36127055-A9992F2C-16B5-4563-AFB5-8D6238B39CD5Q36156532-7CE425DC-8E8C-4EB0-AEAD-AD5D1D96593DQ36213288-899945B1-3E19-45D8-922F-3578D2046769
P2860
Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Comparison of the effector fun ...... ed set of chimeric antibodies.
@en
Comparison of the effector fun ...... ed set of chimeric antibodies.
@nl
type
label
Comparison of the effector fun ...... ed set of chimeric antibodies.
@en
Comparison of the effector fun ...... ed set of chimeric antibodies.
@nl
prefLabel
Comparison of the effector fun ...... ed set of chimeric antibodies.
@en
Comparison of the effector fun ...... ed set of chimeric antibodies.
@nl
P2093
P2860
P4510
P356
P1476
Comparison of the effector fun ...... hed set of chimeric antibodies
@en
P2093
C I Bindon
G T Williams
M Brüggemann
M R Walker
M S Neuberger
R Jefferis
P2860
P304
P356
10.1084/JEM.166.5.1351
P407
P577
1987-11-01T00:00:00Z